A Phase 3 clinical trial testing Boehringer Ingelheim’s oral investigational treatment nerandomilast in people with idiopathic pulmonary fibrosis (IPF) has met its primary goal of demonstrating the ...

The R6 family has been one of, if not the, best-selling lines for Canon. And the more I hear about it, the more I think I might just be putting in a pre-order for the threequel.

The results indicate that both companies’ idiopathic pulmonary fibrosis (IPF) drug candidates might be able to stop or reverse decline in lung function—something no current treatments can offer. But ...

The disease is idiopathic pulmonary fibrosis (IPF), a chronic disorder that causes scarring in the lungs and an irreversible decline in the organ’s function. IPF is a prevalent disease ...

The best Canon lenses for DSLRs are some of the very best in the business. In fact, they're so good that many photographers are still using them on mirrorless cameras instead of the more expensive ...

A University of Colorado professor has won the 2024 Alton Ochsner Award Relating Smoking and Disease for his work into how genetic and environmental factors, including smoking, contribute to a ...

With the International Powerlifting Federation (IPF) moving towards qualified coaches travelling with national teams from January 2026, the South American Federation (FESUPO) has started to ensure ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary fibrosis (IPF). The main end point in the study was lung function based ...